SEC Form 4 · accession 0001209191-18-045819
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Taylor Horn
Officer — Chief Medical Officer
Period of report
Aug 6, 2018
Accepted (ET)
Aug 8, 2018 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $31.54 | Aug 6, 2018 | A | 37,500 | A | — | Aug 5, 2028 | Common Stock | 37,500 | 37,500 | D |
Explanation of responses
- F1This option vests and becomes exercisable as to 25% of the underlying shares on August 6, 2019 and the remainder in equal quarterly installments through the fourth anniversary of the date of grant.